Latest Hyperphosphatemia News
Trial results do not support use of vitamin D receptor activators to prevent cardiovascular events in patients with end-stage renal disease and low intact parathyroid hormone levels.
Analyses demonstrated that an ABI of 1.79 correlated with radiographic evidence of calcified vessels.
In a study, patiromer lowered serum phosphate in patients with hyperkalemia and hyperphosphatemia.
In a study, 42.4% of patients with serum phosphorus of 5.6 to 7 mg/dL lowered their levels to less than 5.5 mg/dL over 2 years.
Patients who received hemodialysis 6 times per week instead of 3 showed improvements in biomarkers of mineral metabolism and left ventricular remodeling.
A new study found that 24-hour urine phosphorus is inversely related to whole-body retention, but is not related to net intestinal absorption.
In a controlled study, a high-phosphate diet increased systolic and diastolic blood pressure and pulse rate in people with normal renal function.
Highest vs lowest quartile of serum phosphorus is independently associated with a nearly 3-fold increased risk of diabetic nephropathy progression.
Patients on hemodialysis who achieved serum phosphate levels below 4.5 mg/dL experienced a decrease in intact fibroblast growth factor 23.
In a study, hemodialysis patients who used phosphate binders had up to a 44% decreased risk of dying from infection than those who did not use the drugs.
Clinicians were able to reduce doses of erythropoiesis-stimulating agents and intravenous iron.
Patients with serum phosphate levels of 4.9 mg/dL or higher upon admission had the worst survival.
Midweek serum phosphate levels can differ from levels measured after a weekend.
Median intact FGF-23 significantly fell by 64% over 1 year of treatment with sucroferic oxyhydroxide or sevelamer.
Meta-analysis shows that nicotinic acid could be a good alternative or add on to traditional phosphate binders, but it is associated with a high rate of adverse events.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
Renal and Urology News Articles
- Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
- Delayed Prostate Cancer Treatment May Up Relapse Risk
- Review: Desmopressin Decreases Nocturia Episodes
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Salvage Prostatectomy May Benefit Some Prostate Cancer Patients